Atlas Trials

Phase II Study of Neoadjuvant Taxotere, Cisplatin, and 5-Fluorouracil in Patients With Gastric or Gastroesophageal Junction Adenocarcinoma

Clinical trial NCT00763646 · UNKNOWN

Trial details

NCT number
NCT00763646
Sponsor
McGill University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Gastric Junction AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Start date
2007-04-01
Primary completion
2010-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.